Back

one-year outcomes of the first 1000 patients implanted with th micra AV leadless pacing system in france: the AV-CESAR cohort study

31 March 2025 (14:30 - 15:15)
Organised by: Logo
Congress Presentation Part of: Pacing therapy Antibradycardia Pacing EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Fawzi kerkouri

University Hospital of Brest, Brest (France)

6 More presentations in this session

Presentation thumbnail
First european experience with a leadless atrial pacemaker
Mr E. von Felten (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
A higher pacing rate more effectively reduces central blood pressure in patients with sick sinus syndrome and hypertension
Doctor S. Heinsar (Tallinn, EE)
Abstract Slides Video
Presentation thumbnail
Predictive factors of high burden of ventricular pacing in patients undergoing permanent pacemaker implantation after transcatheter aortic valve implantation
Doctor C. Chaumont (Rouen, FR)
Abstract Slides Video
Presentation thumbnail
Correlation between manual and automatic measurements of the atrial signal in VDD leadless pacemakers (Micra AV)
Doctor T. Van Weyenbergh (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Comparison of pacing induced cardiomyopathy following leadless vs conventional pacemaker implantation
Doctor Y. Kim (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Pacing therapy

The Event

Event poster

EHRA 2025

31 March 2025 14:30 CET
You may be interested in
thumbnail
Congress Session
How to treat arrhythmias in heart failure
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Webinar
New pacing perspectives for patients with heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources